Proteostasis Therapeutics Appoints Naimish Patel, M.D., C.M., and Elizabeth Tullis, M.D., FRCPC, to its Clinical Advisory Board
28 sept. 2016 07h30 HE
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Sept. 28, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...
Proteostasis Therapeutics Announces Scientific Presentations on New Data at 30th Annual North American Cystic Fibrosis Conference
22 sept. 2016 07h30 HE
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...
Proteostasis Therapeutics to Present at Upcoming Investor Conferences
15 sept. 2016 18h30 HE
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Sept. 15, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...
Proteostasis Therapeutics Announces Closing of Follow-On Public Offering of Common Stock
14 sept. 2016 16h03 HE
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Sept. 14, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused...
Proteostasis Therapeutics Announces Pricing of Public Offering of Common Stock
09 sept. 2016 07h30 HE
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Sept. 09, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...
Proteostasis Therapeutics Issues Mid-Year Corporate Update on Cystic Fibrosis Pipeline Programs
11 août 2016 07h45 HE
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...
Proteostasis Therapeutics Achieves Preclinical Milestone in Astellas Pharma Collaboration
08 août 2016 10h57 HE
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company developing small molecule therapeutics to treat...
Proteostasis Therapeutics Announces Key Leadership Appointments
08 août 2016 10h53 HE
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...
Proteostasis Therapeutics, Inc. Presents New Data Demonstrating Potential for Genotype-Agnostic and Combination Therapies for People with Cystic Fibrosis
30 mars 2016 14h07 HE
|
Proteostasis Therapeutics, Inc.
CAMBRIDGE, Mass., March 30, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...
Proteostasis Therapeutics, Inc. Announces Scientific Presentations at 13th Annual European Cystic Fibrosis Society Basic Science Conference
28 mars 2016 07h30 HE
|
Proteostasis Therapeutics, Inc.
CAMBRIDGE, Mass., March 28, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...